Actively Recruiting
Characterization of Vaginal, Urinary and Fecal Microbiomes in Women with Recurrent Urinary Tract Infections
Led by Hadassah Medical Organization · Updated on 2025-03-19
40
Participants Needed
1
Research Sites
230 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objectives are to evaluate whether variations in vaginal and/or urinary and/or fecal microbiome predispose postmenopausal women to recurrent cystitis. This will be explored using comparison of microbiome profiles between those with recurrent UTI compared to age-matched women without recurrent UTI.
CONDITIONS
Official Title
Characterization of Vaginal, Urinary and Fecal Microbiomes in Women with Recurrent Urinary Tract Infections
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Postmenopausal status
- Two or more documented, culture-positive urinary tract infections in the last six months or three or more infections in the last year (for patients)
- Sterile urine cultures, normal urinalysis, and negative sexually-transmitted PCR urine assay (for control subjects)
You will not qualify if you...
- Neurogenic bladder condition
- Known immunodeficiencies
- Use of antibiotics or probiotics within the previous month
- Known kidney stones or anatomical malformations
- Prior history of urinary tract infections or other urologic abnormalities (for control subjects)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hadassah Medical Center
Jerusalem, Jerusalem, Israel, 9765422
Actively Recruiting
Research Team
A
Ahinoam Lev-Sagie, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here